FGFR1 and non-small cell lung carcinoma: Analysis of the downstream signalling pathways in a FGFR1-amplified NSCLC cell line expressing the wild-type or V561M-mutated receptor, showed that resistance to AZD4547was mediated by the upregulation and high phosphorylation levels of STAT3 [118].